Sanofi | SNY - Sales Revenues

Stock Price
47.47
Daily Change
-0.64 -1.33%
Monthly
-1.43%
Yearly
-9.92%
Q1 Forecast
45.81

Sanofi reported EUR12.2B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
AbbVie USD 16.62B 840M Dec/2025
Amgen USD 9.9B 340M Dec/2025
AstraZeneca USD 15.19B 733M Sep/2025
Bristol-Myers Squibb USD 12.5B 300M Dec/2025
Canopy Growth CAD 66.68M 5.45M Sep/2025
Corcept Therapeutics USD 207.6M 13.2M Sep/2025
Drreddys Laboratories INR 87.27B 1.82B Dec/2025
Eli Lilly USD 19.3B 1.7B Dec/2025
Galapagos EUR 65.3M 4.87M Sep/2025
Genmab DKK 5.86B 580M Jun/2025
GlaxoSmithKline GBP 8.62B 73M Dec/2025
Glaxosmithkline GBP 11.52B 3.54B Sep/2025
J&J USD 24.6B 610M Dec/2025
Merck USD 16.4B 880M Dec/2025
Novartis USD 13.91B 144M Sep/2025
Novartis USD 14.36B 478M Sep/2025
Pacira USD 179.52M 1.58M Sep/2025
Perrigo USD 1.04B 16.3M Sep/2025
Pfizer USD 17.58B 880M Dec/2025
Prestige Brands USD 283.44M 9.34M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Sanofi EUR 11.3B 1.13B Dec/2025
Sanofi EUR 12.2B 3.19B Dec/2025
Supernus Pharmaceuticals USD 192.1M 26.6M Sep/2025
UCB EUR 3.49B 129M Jun/2025
Zoetis USD 2.4B 60M Sep/2025